Affimed N.V.

Symbol: 0HL9.L

LSE

5.31

USD

Market price today

  • -0.6955

    P/E Ratio

  • 0.0006

    PEG Ratio

  • 80.86M

    MRK Cap

  • 0.00%

    DIV Yield

Affimed N.V. (0HL9-L) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

-0.63%

Operating Profit Margin

-7.44%

Net Profit Margin

-7.61%

Return on Assets

-1.09%

Return on Equity

-1.18%

Return on Capital Employed

-1.45%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO:Dr. Andreas Harstrick M.D.
Full-time employees:76
City:Heidelberg
Address:Technologiepark
IPO:2018-02-13
CIK:

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.

General Outlook

When we look at how much money they make before expenses, they keep -0.633% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -7.445%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -7.614%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -1.090% return, is a testament to Affimed N.V.'s adeptness in optimizing resource deployment. Affimed N.V.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.183%. Furthermore, the proficiency of Affimed N.V. in capital utilization is underscored by a remarkable -1.454% return on capital employed.

Stock Prices

Affimed N.V.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.2, while its low point bottomed out at $6.18. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Affimed N.V.'s stock market.

Liquidity Ratios

Analyzing 0HL9.L liquidity ratios reveals its financial health of the firm. The current ratio of 324.96% gauges short-term asset coverage for liabilities. The quick ratio (148.72%) assesses immediate liquidity, while the cash ratio (148.72%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio324.96%
Quick Ratio148.72%
Cash Ratio148.72%

Profitability Ratios

0HL9.L profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -761.36% underscores its earnings before tax deductions. The net income per EBT, 100.00%, and the EBT per EBIT, 102.27%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -744.47%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-761.36%
Net Income per EBT100.00%
EBT per EBIT102.27%
EBIT per Revenue-744.47%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.25, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding149
Days of Inventory Outstanding7
Operating Cycle7.44
Days of Payables Outstanding266
Cash Conversion Cycle-258
Payables Turnover1.37
Inventory Turnover49.09
Fixed Asset Turnover1.07
Asset Turnover0.14

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -7.37, and free cash flow per share, -7.62, depict cash generation on a per-share basis. The cash per share value, 2.58, showcases liquidity position. Lastly, the operating cash flow sales ratio, -7.93, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-7.37
Free Cash Flow per Share-7.62
Cash per Share2.58
Operating Cash Flow Sales Ratio-7.93
Free Cash Flow to Operating Cash Flow Ratio1.03
Cash Flow Coverage Ratio-5.86
Short Term Coverage Ratio-18.90
Capital Expenditure Coverage Ratio-29.57
Dividend Paid and Capex Coverage Ratio-29.57

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 19.36%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.33, we discern the balance between debt and equity financing. The long-term debt to capitalization, 18.34%, and total debt to capitalization, 24.55%, ratios shed light on its capital structure.

cards.indicatorcards.value
Debt Ratio19.36%
Debt Equity Ratio0.33
Long Term Debt to Capitalization18.34%
Total Debt to Capitalization24.55%
Cash Flow to Debt Ratio-5.86
Company Equity Multiplier1.68

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.93, provides a glimpse into top-line earnings distributed across each share. Net income per share, -7.09, reflects the portion of profit attributed to each share. The book value per share, 3.87, represents the net asset value distributed per share, while the tangible book value per share, 3.87, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.93
Net Income Per Share-7.09
Book Value Per Share3.87
Tangible Book Value Per Share3.87
Shareholders Equity Per Share3.87
Interest Debt Per Share1.26
Capex Per Share-0.25

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -67.39%, indicates top-line expansion, while the gross profit growth, -67.39%, reveals profitability trends. EBIT growth, -19.42%, and operating income growth, -19.42%, offer insights into operational profitability progression. The net income growth, -23.18%, showcases bottom-line expansion, and the EPS growth, -17.38%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-67.39%
Gross Profit Growth-67.39%
EBIT Growth-19.42%
Operating Income Growth-19.42%
Net Income Growth-23.18%
EPS Growth-17.38%
EPS Diluted Growth-17.38%
Weighted Average Shares Growth4.94%
Weighted Average Shares Diluted Growth4.94%
Operating Cash Flow Growth-5.13%
Free Cash Flow Growth-8.00%
10-Year Revenue Growth per Share-75.94%
5-Year Revenue Growth per Share-76.25%
3-Year Revenue Growth per Share-73.06%
10-Year Operating CF Growth per Share-92.43%
5-Year Operating CF Growth per Share-190.34%
3-Year Operating CF Growth per Share-217.57%
10-Year Net Income Growth per Share59.78%
5-Year Net Income Growth per Share-120.31%
3-Year Net Income Growth per Share-43.09%
10-Year Shareholders Equity Growth per Share105.77%
5-Year Shareholders Equity Growth per Share-41.65%
3-Year Shareholders Equity Growth per Share-55.14%
Receivables Growth-100.00%
Inventory Growth-26.27%
Asset Growth-51.55%
Book Value per Share Growth-63.98%
Debt Growth5.73%
R&D Expense Growth-3.90%
SGA Expenses Growth-23.07%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 75,571,807.515, captures the company's total value, considering both debt and equity. Income quality, 1.04, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 1.77, gauges operational efficiency, while the research and development to revenue, 682.46%, highlights investment in innovation. The ratio of intangibles to total assets, 0.03%, indicates the value of non-physical assets, and capex to operating cash flow, 3.38%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value75,571,807.515
Income Quality1.04
Sales General and Administrative to Revenue1.77
Research and Development to Revenue682.46%
Intangibles to Total Assets0.03%
Capex to Operating Cash Flow3.38%
Capex to Revenue-26.80%
Capex to Depreciation-217.31%
Stock-Based Compensation to Revenue77.00%
Graham Number24.85
Return on Tangible Assets-109.07%
Graham Net Net-0.04
Working Capital58,281,000
Tangible Asset Value57,782,000
Net Current Asset Value44,838,000
Average Receivables0.5
Average Payables16,643,000
Average Inventory545,500
ROIC-135.20%
ROE-1.83%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.27, and the price to book ratio, 1.27, reflect the market's valuation relative to the company's book value. The price to sales ratio, 5.39, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.66, and price to operating cash flows, -0.67, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.27
Price to Book Ratio1.27
Price to Sales Ratio5.39
Price Cash Flow Ratio-0.67
Enterprise Value Multiple-0.93
Price Fair Value1.27
Price to Operating Cash Flow Ratio-0.67
Price to Free Cash Flows Ratio-0.66
Price to Tangible Book Ratio1.65
Enterprise Value to Sales5.43
Enterprise Value Over EBITDA-0.74
EV to Operating Cash Flow-0.69
Earnings Yield-111.18%
Free Cash Flow Yield-119.63%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Affimed N.V. (0HL9.L) on the LSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.696 in 2024.

What is the ticker symbol of Affimed N.V. stock?

The ticker symbol of Affimed N.V. stock is 0HL9.L.

What is company IPO date?

IPO date of Affimed N.V. is 2018-02-13.

What is company current share price?

Current share price is 5.310 USD.

What is stock market cap today?

The market cap of stock today is 80858025.000.

What is PEG ratio in 2024?

The current 0.001 is 0.001 in 2024.

What is the number of employees in 2024?

In 2024 the company has 76.